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ABSTRACT
Linking emulsion PCR (LE-PCR) enables formation
of minichromosomes preserving phase information
of two polymorphic loci, hence the haplotype.
Emulsion PCR confines two amplicons of two linked
polymorphic sites on a single template molecule
to one aqueous-phase droplet. Linking PCR uses
biotinylated, overlapping linking primers to con-
nect these amplicons in the droplet. After LE-PCR,
unlinked amplicons are removed on streptavidin-
coated magnetic beads and single-stranded runoff
products are capped by primer extension. Quantit-
ative ASPCR can then be used to ascertain the
haplotypes of the two polymorphic loci on the
minichromosomes. Using LE-PCR, we determined
the human paraoxonase-1 [PON1] molecular
haplotypes at three loci ( 909g>c, L55M, Q192R)
in women who were compound heterozygotes for
 909g>c/L55M (n = 89),  909g>c/Q192R (n = 77)
and L55M/Q192R (n = 68). We observed a strong
association between PON1 substrate specificity
(paraoxon/phenylacetate substrate activity ratios)
and  909g>c/Q192R haplotype. We have demon-
strated here a powerful molecular haplotyping tech-
nology that can be applied in population studies.
INTRODUCTION
Haplotypes may be superior to genotypes for association
studies. For example, when a promoter polymorphism affects
transcription efﬁciency and a missense polymorphism in the
same gene affects protein function, individuals heterozygous
for these two polymorphisms have identical genotypes but
may have different phenotypes (1). Currently, haplotypes
are ascertained primarily by statistical inference using various
algorithms including Expectation–Maximization (EM) [e.g.
TagSNPs (2)] and Bayesian [e.g. PHASE (3)]. The develop-
ment of technology that allows molecular determination of
haplotypes is limited; most available methods are not suitable
for population studies.
First, there are methods based on genotyping isolated
chromosomes or clones, such as single-chromosome typing
of individual sperm (4). More recent examples are cloning
and genotyping fosmid/cosmid pools (5) and typing somatic
hybrids (6). These methods are not easily applied to large
population studies. A second method involves long-range
PCR based on allele-speciﬁc ampliﬁcation at one polymorph-
ism (7), a method that recently has been combined with
intramolecular ligation (8). Methods of this type are limited
by the ability to carry out robust long-range PCR, especially
in the context of allele speciﬁcity. A third proposed method
would read haplotypes directly on single molecules by coin-
cidence counting ﬂuorescent oligonucleotides hybridized to
polymorphic sites (9). This method would require specialized
instrumentation and needs substantial probe development.
Finally, there are methods based on single molecule PCR.
The oldest approach was based on limiting dilution (10),
a method still in use (11). Limiting dilution PCR requires a
large number of reactions to obtain a single haplotype, both
because of the dilution requirement and the inefﬁciency of
PCR ampliﬁcation from a single template molecule. A
newer approach uses a gel to separate templates, permitting
‘polonies’ to be genotyped to determine haplotypes (12). This
method is effective, but again requires specialized instru-
mentation. Another approach would be emulsion PCR
(13,14). Emulsion PCR has been combined with beads and
ﬂuorescence activated cell sorter (FACS) measurements to
permit genotyping and could theoretically be extended to hap-
lotyping (15). In this study, we have developed LE-PCR,
which combines linking PCR (16) and emulsion PCR to pro-
duce a haplotyping technology applicable to long DNA
molecules that does not require any special instrumentation
beyond real-time PCR.
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Study subjects
The study population is from an on-going study at the Mount
Sinai Children’s Environmental Health Center to assess, pro-
spectively, infant growth and neurodevelopment associated
with pesticide exposure in urban New York City. The study
protocol was approved by the Institutional Review Board.
The study consists of pregnant women of multi-ethnic origin
(Caucasian, African-American, and Hispanic of Caribbean
origin) at 26–30 weeks of gestational age. A detailed descrip-
tion of the population has previously been published (17).
Leukocyte DNA and plasma were isolated from blood as
previously described (18).
Emulsion formation
The oil phase contained 4.5% Span 80 (#85548, Fluka), 0.4%
Tween 80 (#S-8074, Sigma), 0.05% Triton X-100 (#T-9284,
Sigma) made up to 100% with mineral oil (#M-3516, Sigma).
Theaqueousphasecontained1·Taqbuffer (10mMTris–HCl,
pH 8.0, 50 mM KCl), 300 mM each dNTP, 2.5 mM MgCl2,
50mMM e 4NCl, 1 mM each outside primer (o indicates outside
primer), 0.1 mM each jumping primer, 100 mU/ml Amplitaq
Gold (ABI) and 1 ng/ml human genomic DNA. Emulsion
primers were (* indicates reverse primer): 192/ 909*,
Bio-GCCCCATTATCAGTGTGGGACCTGAGCACTTTTA-
TGGCACAA; 192/ 909, Bio-AAAGTGCTCAGGTCCCA-
CACTGATAATGGGGCATTTGAGTAA; 192o*, CAAAA-
TCAAATCCTTCTGCCACCACTCGAA;  909o, ACATG-
GAGCAAATCATTCACAGTAA; 192/55*, Bio-CTGTGAG-
TGTTTTCTTTTGGGACCTGAGCACTTTTATGGCACA-
A; 192/55, Bio-AAAGTGCTCAGGTCCCAAAAGAAAAC-
ACTCACAGAGCTAATGAA; 192o* & 55o, CTGTACTT-
TCTGTTCTCTTTTCTGGCAGAA; 55/ 909*, Bio-GCCC-
CATTATCAGTGCTGTACTTTCTGTTCTCTTTTCTGGC-
AGAA; 55/ 909, Bio-AAGAGAACAGAAAGTACAGCA-
CTGATAATGGGGCATTTGAGTAA; 909o & 55o*, AAA-
GAAAACACTCACAGAGCTAATGAA.
LE-PCR
Carry out 30 cycles of PCR for 1 min 67 C, 1 min 60 C, 30 s
94 C following incubation at 95 C for 9 min to activate
the polymerase and followed by a ﬁnal incubation for 7 min
at 60 C.
PCR cleanup
Add 3 volumes of NX buffer (100 mM NaCl, 1% Triton
X-100, 10 mM Tris–HCl, pH 7.5, 1 mM EDTA) to 5 volumes
emulsion (oil plus aqueous phases). Vortex 20 s. Separate
the phases in a microcentrifuge and remove most of the oil.
Complete the cleanup with a Qiagen PCR puriﬁcation kit and
elute in 40 ml. The Qiagen PCR puriﬁcation kit tolerates oil
carryover.
Removal of unlinked amplicons
Wash 3 ml Dynabeads Myone streptavidin (Dynal Biotech)
3· in B&W buffer (10 mM Tris–HCl, pH 7.5, 1 mM EDTA,
2 M NaCl) and 1· in Taq buffer. Resuspend the beads in 40 ml
eluate plus 4 ml1 0 · Taq buffer. Incubate at room temperature
for 30 min, magnetize and save the supernatant.
Capping of runoff products
Each capping reaction used 5 ml of the supernatant in a 50 ml
PCR reaction with 1· Taq buffer, 1.5 mM MgCl2, 200 mM
each dNTP, 1 mM each capping oligonucleotide, 2.5 U Taq
DNA polymerase (not hot start). Incubate at 55 C for 30 min.
Capping oligonucleotides were: 192/ 909, AAAAAAGCCC-
CATTATCAGTG-P/AAAAAAAAAGTGCTCAGGTCCCA-P;
192/55, AAAAAACTGTGAGTGTTTTCTT-P/AAAAAAA-
AAGTGCTCAGGTCCCA-P; 55/ 909, AAAAAAGCCCC-
ATTATCAGTG-P/AAAAAAAAAGAGAACAGAAAGTA-P.
Determination of haplotypes by ASPCR
Each allele-speciﬁc PCR (ASPCR) reaction used 2 mlo f
capped product in a 20 ml PCR reaction. All four possible
reactions were assembled with one ASPCR primer per SNP.
PCR was carried out in 1·Taq buffer, 1.5 mM MgCl2, 200 mM
each dNTP, 1 mM each ASPCR primer, 2.5 U Amplitaq Gold
DNA polymerase. 2% glycerol, 1· BSA (NEB), and 1· SYBR
green in a LightCycler with cycling 1 min 55 C, 1 min 72 C,
30 s 94 C after an initial incubation at 95 C for 9 min to
activate the polymerase. Ct values were determined by the
LightCycler second derivative algorithm. ASPCR primers
were: 192T, CAAATACATCTCCCAGGATT; 192C, CAAA-
TACATCTCCCAGGATC; 55/192T, AGAAACTGGCTCT-
GAAGACT; 55/192A, AGAAACTGGCTCTGAAGACA;
55/ 909A, CCATTAGGCAGTATCTCCAA; 55/ 909T,
CCATTAGGCAGTATCTCCAT;  909C, GCAGACAGCAG-
AGAAGAGAC;  909G, GCAGACAGCAGAGAAGAGAG.
Determine the average Ct values for the two possible pairs.
For example, consider average Ct for 192T/ 909C + 192C/
 909G and for 192T/ 909G + 192C/ 909C. Subtract to
obtain DCt. If the absolute value of DCt > 1 and the individual
Ct values of 192T/ 909C and 192C/ 909G are both greater
than or less than the individual Ct values of 192T/ 909G and
192C/ 909C, call the haplotype based on the lowest Ct val-
ues. If a haplotype cannot be called, repeat the entire LE-PCR
experiment. This calculation assumes all ASPCR primers are
equally efﬁcient when amplifying PCR products made without
using an emulsion, as was the case for our four examples.
If not, appropriate corrections must be employed.
PON1 phenotypes
PON1 activities with paraoxon and phenylacetate substrates
were determined spectrophotometrically (18,19).
RESULTS AND DISCUSSION
To illustrate the power of our molecular haplotyping techno-
logy, we chose the paraoxonase-1 (PON1) gene depicted in
Figure 1 (20). PON1 is an enzyme with multiple activities,
including detoxiﬁcation of organophosphates. It is believed
to be important in preventing neurotoxic damage, and has
also been implicated in vascular disease (21,22) although the
mechanisminthelatterisuncertain(23).Commonpolymorph-
isms in the 50 regulatory region affect transcription (24).
Although the  108 locus is most important for determining
transcription level, the polymorphisms at the  909 and  108
loci are in strong linkage disequilibrium (LD) (18). PON1 also
contains two common missense polymorphisms, L55M and
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stability (26), and the latter the relative rate of hydrolysis
of certain organophosphates compared with phenylacetate
(27). We chose to examine the  909 polymorphism because
it gave us the largest distance to Q192R. As illustrated below,
haplotype inference would be a good predictor of molecular
haplotypes for  909g>c and L55M and for L55M and
Q192R, but would be an imprecise predictor for the most
important functional alleles,  909g>c and Q192R. We had
previously conducted a study of the relationship between
PON1 phenotypes and genotypes in 378 pregnant women
from multi-ethnic backgrounds (18). Although single nucle-
otide polymorphisms (SNPs) in PON1 were signiﬁcantly
associated with enzymatic activity, the use of phenylacetate
as the substrate resulted in a considerable overlap of the
PON1 activity across genotypes. In this study, we applied
the newly developed LE-PCR molecular haplotyping method
to this population to demonstrate that the method is robust
in a population study setting; haplotype information from this
method can better clarify the genetic inﬂuence on PON1
expression.
Figure 1 illustrates the overall design of LE-PCR for
determining haplotypes for three common polymorphisms,
 909g>c, L55M and Q192R in human PON1, a gene of
27 kb including the promoter region. PCR amplicons are
produced at the two polymorphic loci  909g>c (yellow
amplicon) and L55M (red amplicon) from a single template
residing in an aqueous droplet of an emulsion. With the use
of linking primers, the amplicons are fused into a  909g>c/
L55M minichromosomes. The same procedure can form mini-
chromosomes containing  909g>c/Q192R or L55M/Q192R.
Consequently, LE-PCR can produce two minichromosomes
conserving phase information of two polymorphic loci on
the two corresponding autosomes, i.e. haplotypes.
Emulsiﬁcation is a critical step. Oil-water emulsions
were produced based on previously published methods (14).
Emulsiﬁcation involved vortexing one part aqueous phase
and two parts oil phase (typical volume 150 ml) for 5 min.
We examined the effect of this treatment on duplex DNA
length and found that the majority of the DNA remained
large enough to fall outside the separation range in a 1%
agarose gel (data not shown). By limiting the human genomic
DNA concentration to 1 ng/ml(  300 haploid genome
equivalents/ml), the chance of more than one template being
found in a 10 mm diameter dropletis <1%. This chance is even
smaller in actual experiments as smaller droplets were routi-
nely observed by light microscopy (data not shown). Haplo-
typing failures are characterized by the absence of difference
betweenCtvaluesfromASPCRforthe two possiblehaplotype
pairs. We found that all such failures occurred in the emulsion
PCR step and could not be rescued by repeating the puriﬁca-
tion and assay steps. At the beginning, haplotype failures
occurred  20–30% of the time, but after repeatedly forming
the emulsions, the failure rate dropped to <5%.
Figure 2A illustrates linking primer design. Of the 42 nt
in the 50-biotinylated primers, the 32 nt at the 50 end were
complementary to one another. As illustrated in Figure 2B,
the 26 nt at the 30 end of each linking primer (red) that were
complementary to the genomic template acted together with a
corresponding outside primer (blue or green) to form an amp-
licon at each polymorphic site. The linkage between the poly-
morphic sites was only required before template denaturation.
The 16 nt on the 50 end of each linking primer contained
sequences derived from the second amplicon. Figure 2C illus-
trates all of the LE-PCR products. The biotin-containing amp-
licons contained one strand extended from a linking primer
and a complementary strand extended from an outside primer.
These amplicons contained identical sequences at the biotin-
containing ends. Self-priming led to the formation of the long
minichromosomes which no longer contained biotins. For
clarity, the sequences in the linking primers are depicted
in red in the linked product. The unlinked biotinylated amp-
licons were removed on streptavidin-coated magnetic beads.
Figure 2D illustrates how outside primer runoff products were
capped with oligo(dT) by primer extension on 30-phosphate-
blocked capping oligonucleotides. The capping oligonuc-
leotides were partially complementary to and overlapped
the 30 ends of the runoff products. The 30 phosphate prevented
the capping oligonucleotides from acting as primers. Thus, the
runoff products are themselves extended using the capping
oligonucleotide as a template. We found the capping step to
be absolutely necessary to prevent randomization of alleles
during subsequent ASPCR assays.
We determined haplotypes for the 89, 77 and 68 individuals
in our total population of 378 women, in a previous study (17),
who were compound heterozygotes at  909g>c/L55M,
 909g>c/Q192R and L55M/Q192R, respectively. L55M/
Q192R displayed the strongest LD, with only 1 of 68 com-
pound heterozygotes with diplotype 55L/192Q and 55M/192R.
 909g>c/L55M displayed strong but less complete LD, with
only 9 of 89 compound heterozygotes with diplotypes  909c/
55L and  909g/55M. On the other hand,  909g>c/Q192R
displayed much less LD, with 22 compound heterozygotes
with diplotypes  909c/192R and  909g/192Q versus 55 com-
pound heterozygotes with diplotypes  909c/192Q and
 909g/192R.
Figure 3 illustrates the utility of this technology for deter-
mining haplotype–phenotype associations in our population
study. We determined the PON1 activity in the plasma of
subjects heterozygous for both  909g>c and Q192R using
both phenylacetate and paraoxon as substrates. The results
clearly demonstrate that individuals carrying higher express-
ingpromoter( 909g)coupledwithpolymorphismwithhigher
paraoxon-metabolizing activity (192R), labeled haplotype 1,
Figure1. Linkingemulsion-PCRwithhumanPON1.Theexons(orange)ofthe
27 kb human PON1 gene (black) are drawn to scale. The location of the biotin
(Bio) on the linking primer is indicated on each of the PCR amplicons contain-
ing either the promoter polymorphism  909g>c (yellow), the missense poly-
morphismL55Minexon3(redandblue)orthemissensepolymorphismQ192R
in exon 6 (green). The arrows indicate the derivation of minichromosomes in
theemulsion: 909g>c/L55M(yellowandred), 909g>c/Q192R(yellowand
green) and L55M/Q192R (blue and green).
Nucleic Acids Research, 2005, Vol. 33, No. 8 2617had higher paraoxon/phenylacetate activity ratios than indi-
viduals of haplotype 2 (P < 0.001 for both Mann–Whitney
Wilcoxon and t-tests).
In summary, we have developed a single-molecule
haplotyping technology based on a combination of linking
and emulsion PCR (LE-PCR). This technology is robust
and feasible for application to population studies, as we
have demonstrated by detailed analysis of the relationship
between PON1 haplotypes and phenotypes.
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